Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8 USD | +12.68% | +12.99% | +75.82% |
May. 31 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
May. 31 | Larimar Therapeutics Shares Rise 15% Nomlabofusp Selected for FDA Program | DJ |
Business Summary
Number of employees: 42
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 19-12-31 | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 20-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
John Berman
ADM | Chief Administrative Officer | 57 | 16-12-31 |
Compliance Officer | - | 16-11-30 | |
Russell Clayton
CTO | Chief Tech/Sci/R&D Officer | 63 | 23-07-16 |
Gopi Shankar
PRN | Corporate Officer/Principal | 53 | 23-02-06 |
Comptroller/Controller/Auditor | - | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-05-27 |
Frank Thomas
BRD | Director/Board Member | 54 | 13-12-31 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 23-10-02 |
Chief Executive Officer | 65 | 19-12-31 | |
Joseph Truitt
CHM | Chairman | 59 | 20-05-27 |
Thomas Hamilton
BRD | Director/Board Member | 56 | 20-05-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,802,017 | 62,876,711 ( 98.55 %) | 0 | 98.55 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.82% | 510M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- LRMR Stock
- Company Larimar Therapeutics, Inc.